Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
208
Views
14
CrossRef citations to date
0
Altmetric
Review

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Dave Singh1 Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UKCorrespondence[email protected]
,
Anthony D D’Urzo2 Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada
,
James F Donohue3 Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Pulmonary Critical Medicine, Chapel Hill, NC, USAORCID Iconhttps://orcid.org/0000-0002-4439-6866
ORCID Icon,
Edward M Kerwin4 Clinical Research Institute, Medford, OR, USAORCID Iconhttps://orcid.org/0000-0002-1697-9036
ORCID Icon,
Eduard Molins5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain
,
Ferran Chuecos5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain
,
Anna Ribera5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain
&
Diana Jarreta5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain
 show all
Pages 2835-2848 | Published online: 06 Dec 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kjell Larsson, Ann Ekberg-Jansson, Caroline Stridsman, Malin Hanno & Lowie E G W Vanfleteren. (2021) Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 909-918.
Read now
Leif Bjermer, Isabelle H Boucot, François Maltais, Edward M Kerwin, Ian P Naya, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson & Claus F Vogelmeier. (2021) Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1939-1956.
Read now
Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman & Robert A. Wise. (2021) Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update. Expert Review of Respiratory Medicine 15:9, pages 1093-1106.
Read now
Gerard Criner & Sean Duffy. (2021) Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium + olodaterol. Current Medical Research and Opinion 37:2, pages 275-284.
Read now

Articles from other publishers (10)

Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2022) Dual bronchodilation for the treatment of COPD: From bench to bedside. British Journal of Clinical Pharmacology 88:8, pages 3657-3673.
Crossref
Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella & Marco Scalese. (2021) Which LABA/LAMA should be chosen in COPD patients in real life?. Pulmonary Pharmacology & Therapeutics 71, pages 102076.
Crossref
J.M. Figueira Gonçalves, R. Golpe, C. Esteban, M. Acosta-Sorensen, I. Veiga & I. Guzmán-Peralta. (2021) Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC guideline vs. GOLD. Revista Clínica Española (English Edition) 221:9, pages 536-539.
Crossref
J.M. Figueira Gonçalves, R. Golpe, C. Esteban, M. Acosta-Sorensen, I. Veiga & I. Guzmán-Peralta. (2021) Discordancia del tratamiento de la enfermedad pulmonar obstructiva crónica según la guía GesEPOC vs. GOLD. Revista Clínica Española 221:9, pages 536-539.
Crossref
Dave Singh. (2021) Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology 26:7, pages 643-651.
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021) Future concepts in bronchodilation for COPD: dual- versus monotherapy . European Respiratory Review 30:160, pages 210023.
Crossref
Kristián Brat, Jaromír Zatloukal, Kateřina Neumannová, Eva Voláková, Ondřej Kudela, Michal Kopecký, Marek Plutinský & Vladimír Koblížek. (2021) Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease. Vnitřní lékařství 67:4, pages 230-239.
Crossref
Jaromir Zatloukal, Kristian Brat, Katerina Neumannova, Eva Volakova, Karel Hejduk, Eva Kocova, Ondrej Kudela, Michal Kopecky, Marek Plutinsky & Vladimir Koblizek. (2020) Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers 164:4, pages 325-356.
Crossref
Alexander G. Mathioudakis, Jørgen Vestbo & Dave Singh. (2020) Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 463-474.
Crossref
Roland Buhl, Dave Singh, Alberto de la Hoz, Wenqiong Xue & Gary T. Ferguson. (2020) Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies. Advances in Therapy 37:8, pages 3485-3499.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.